Cellebrite DI Ltd. (CLBT)
(Real Time Quote from BATS)
$13.76 USD
+0.11 (0.81%)
Updated Aug 6, 2025 12:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Cellebrite DI Ltd. has a market cap of $3.27B, which represents its share price of $13.65 multiplied by its outstanding shares number of 239.47M. As a mid-cap company, CLBT's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CLBT 13.76 +0.11(0.81%)
Will CLBT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CLBT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLBT
Match Group (MTCH) Lags Q2 Earnings Estimates
Cellebrite DI Ltd. (CLBT) Tops Q1 Earnings Estimates
CLBT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Arteris, Inc. (AIP) Reports Q1 Loss, Tops Revenue Estimates
CCC Intelligent Solutions Holdings Inc. (CCCS) Meets Q1 Earnings Estimates
SMGZY or CLBT: Which Is the Better Value Stock Right Now?
Other News for CLBT
Greenhaven Road Capital Main Fund Q2 2025 Investor Letter
Cellebrite DI Ltd (CLBT) Secures DOJ Sponsorship for FedRAMP High Authorization | CLBT stock news
Cellebrite (CLBT) Advances FedRAMP High Authorization with DOJ Support | CLBT Stock News
U.S. Department of Justice to Sponsor Cellebrite for FedRAMP ATO | CLBT Stock News
Cellebrite announces U.S. DOJ to sponsor platform for FedRAMP ATO